Latest Global Markets News

Peninsula Energy has locked in a $15 million debt facility from Davidson Kempner to advance commissioning at its Lance uranium project and support an upcoming equity raise. The funding aims to sustain momentum towards production resumption and ASX relisting.

Telix Pharmaceuticals has achieved a key milestone with its next-generation prostate cancer imaging agent, Gozellix, receiving a permanent HCPCS code from U.S. Medicare. This paves the way for broader reimbursement and market adoption starting October 2025.

Kingsland Minerals has initiated metallurgical testing to explore rutile and gallium extraction from its Leliyn Graphite Project, aiming to enhance project value amid shifting global supply chains.

BlackRock Investment Management announces an estimated 33.12 cents per unit distribution for its iShares Global High Yield Bond (AUD Hedged) ETF for the June 2025 period, predominantly sourced from foreign income. The detailed tax breakdown aims to assist investors, especially non-residents, in managing withholding tax obligations.

BlackRock Investment Management has released the estimated distribution components for the iShares Core MSCI World ex Australia ESG ETF for the period ending 30 June 2025, outlining key income sources and tax implications for investors.

Betashares Capital Ltd has released the estimated annual distribution components for its Global Sustainability Leaders ETF (ETHI) for the 2024-25 financial year, highlighting a complex mix of foreign income and capital gains.

EVE Health Group has placed its first commercial purchase order for Dyspro™, a cannabinoid-based pharmaceutical targeting painful menstruation, signaling a key step toward market entry. The product is set for manufacturing and distribution within weeks, tapping into a rapidly growing global women’s health market.

Sparc Hydrogen, in partnership with the University of Adelaide, has won a $2.75 million Australian Government grant to advance its pioneering green hydrogen pilot plant. This funding underscores the commercial promise of its novel photocatalytic water splitting technology.

Horseshoe Metals has secured crucial Direct Shipping Ore mining approval for its Horseshoe Lights Copper-Gold Project, setting the stage for imminent production and early revenue generation from high-grade copper stockpiles.

Neurizon Therapeutics has inked a pivotal global licensing deal with Elanco Animal Health, unlocking critical intellectual property and data to accelerate the development and commercialisation of its lead drug candidate NUZ-001 for neurodegenerative diseases including ALS.

EMVision Medical Devices has activated five of six pivotal trial sites for its emu™ bedside brain scanner, advancing towards FDA clearance while launching a parallel innovation study in Australia.

BlackRock Investment Management (Australia) Limited has announced the Distribution Reinvestment Plan (DRP) prices for its suite of Australian-domiciled iShares ETFs for the June 2025 distribution period. The update includes detailed pricing across multiple funds and important investor compliance reminders.